Accession Number: | 0000874015-17-000063 |
Date: | 2017-10-18 |
Issuer: | IONIS PHARMACEUTICALS INC (IONS) |
Original Submission Date: |
PARSHALL B LYNNE
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD, CA 92010
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2017-10-18 | M | 7,785 | a | $14.69 | 33,526 | direct | ||
COMMON STOCK | 2017-10-18 | S | 7,785 | d | $65.00 | 25,741 | direct | ||
COMMON STOCK | 2017-10-18 | M | 8,333 | a | $39.87 | 34,074 | direct | ||
COMMON STOCK | 2017-10-18 | S | 8,333 | d | $65.00 | 25,741 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 14.69 | 2017-10-18 | deemed execution date | M | 7,785 (d) | 2017-01-02 | 2020-01-29 | common stock 7,785 | $14.69 | 0 | direct | |
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 39.87 | 2017-10-18 | deemed execution date | M | 8,333 (d) | 2015-01-02 | 2021-01-01 | common stock 8,333 | $39.87 | 74,167 | direct |
ID | footnote |
---|---|
f1 | acquired as a result of exercising a stock option pursuant to rule 10b5-1 trading plan. the purchase and sale reported on this form 4 was effective pursuant to rule 10b5-1 trading plan adopted by the reporting person on 8/8/2017. |
f2 | grant of 1/2/2014 to reporting person of stock options under the ionis pharmaceuticals, inc. 2011 equity incentive plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2015. thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,625 shares per year. following this transaction, the option was exercisable as to 69,010 on 10/18/2017. |